Subscribe to Search results

At the meeting of the regional transfusion directors, it was noted that the most risky populations might had been identifiable by anti-HBc markers, however no further discussion took place.

Published on:

At a meeting of the UK Working Party on Transfusion-Associated Hepatitis, Dr Barbara observed that the anti-HBc test had the value of association with Hepatitis B and NANBH as well as AIDS.

Published on:

The CBLA Working Group on AIDS discussed surrogate screening and asked Dr Brian McClelland to submit outline proposals for prospective study.

Published on:

The CBLA Working Group on AIDS agreed that a protocol for a study should be drawn up.

Published on:

Dr Wallington presented the protocol for a study on surrogate screening at the CBLA Central Committee for Research and Development in Blood Transfusion.

Published on:

Application for funding from the MRC was made for the prospective study.

Published on:

Direct testing for HTLV-3 was thought to be in the offing.

Published on:

Universal screening of blood donations for HIV commenced in the UK.

Published on:

Professor Robert Gallo announced that he had identified the virus causing AIDS.

Published on:

An internal DHSS minute said that a screening test needed to be introduced "as quickly as possible".

Published on:

An article in The Guardian noted the use of a UK screening test.

Published on:

The Lancet reported that 34% of people with haemophilia receiving pooled clotting factors had tested positive.

Published on:

The first meeting of the Working Group on AIDS unanimously agreed that donors should undergo HTLV-3 antibody testing.

Published on:

The CMO made a public statement following a report in The Guardian of two cases of alleged AIDS transmission through blood donations.

Published on:

Ministers were asked to approve the use of a screening test for AIDS antibodies in the NBTS.

Published on:

Approval was granted for the use of a screening test for AIDS antibodies in the NBTS.

Published on:

Professor Arthur Bloom wrote to the DHSS: more testing staff were needed as was funding to develop British HTLV-3 antibody test kits.

Published on:

The EAGA met for the first time and discussed work being carried out to develop a screening test.

Published on:

The DHSS told the chair of the regional transfusion directors in England that it was in the interests of the blood services to delay testing until tests had been properly evaluated.

Published on:

Several countries had started screening blood donations; the UK was still evaluating tests and considering how best to implement blood donation screening.

Published on: